RYTHM's Q4 Loss Narrows Y/Y on Licensing Revenue Growth

Core Insights - RYTHM, Inc. (RYM) shares increased by 5.3% following the company's quarterly results, outperforming the S&P 500 Index, which declined by 2.1% during the same period [1] - The company reported a net loss of $6.62 per share for Q4 2025, an improvement from a loss of $15.32 per share in the previous year [1] Financial Performance - Revenue from continuing operations reached $10.7 million, a significant rise from $0.01 million in the same quarter last year [2] - Gross profit was $8 million compared to a gross loss of $0.07 million a year earlier, indicating improved margins [2] - The net loss for the quarter was $13.6 million, down from $24.4 million in Q4 2024 [2] - RYTHM reported a gross margin of approximately 75% in Q4, up from 34% in the prior quarter [3] - The company recorded an operating loss of $12.9 million, influenced by an $8.5 million non-cash impairment charge [3] - For the full year 2025, RYTHM's revenues totaled $17.3 million, up from $0.01 million in 2024, with a net loss narrowing to $33.3 million from $41.7 million [11] Strategic Initiatives - The company underwent a rebranding and strategic pivot towards the hemp-derived THC market, with a focus on brands like RYTHM, Dogwalkers, and Señorita [5] - Licensing revenue was significant, contributing approximately $7 million in Q4, including two months from a recent brand acquisition [6] - RYTHM expanded its distribution of hemp-derived THC beverages to over 6,000 locations across 18 states, including a notable rollout in Circle K convenience stores [9] - The launch of Señorita THC Margaritas and RYTHM Beverages at Chicago's United Center marked a significant milestone in the THC beverage market [10] Market Dynamics - Management highlighted rising consumer demand for THC products despite regulatory challenges, focusing on expanding access to THC beverages in retail and entertainment venues [7] - The acquisition of brand intellectual properties during 2025 is expected to strengthen RYTHM's market presence and support its licensing strategy [12] - Ongoing regulatory uncertainty surrounding hemp-derived THC products poses potential risks to market dynamics, but the company remains committed to building consumer-facing brands [13]